Gilead Sciences (GILD.O) announced that in a late-stage trial, its injectable tr...
California health technology firm Evidation is making its app for logging sympto...
A panel of experts advising the Food and Drug Administration announced earlier t...
Initially thought of as a potential game-changer for metabolic-associated steato...
Phase 3 trial results for Loqtorzi (toripalimab) and Avastin (bevacizumab) show ...
Pfizer’s gene therapy for Duchenne muscular dystrophy failed to improve motor fu...
The FDA has accepted Eisai’s application for a monthly intravenous maintenance d...
Zealand Pharma has disclosed that Boehringer Ingelheim has published findings fr...
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as ...
The FDA’s advisory committee has raised concerns about Eli Lilly’s Alzheimer’s d...
An end is drawing close for Illumina’s multibillion-dollar pursuit of Grail. The...
According to the FDA, the current dominant strain of COVID-19 should be a key fo...
In a follow-up study conducted on approximately 160 people, it was discovered th...
The government of Victoria in Australia announced that a highly virulent variant...
Soterios Pharma plans to proceed to phase 3 trials after its 1% Alopecia areata ...
Scientists have discovered a new antibiotic derived from AstraZeneca drugs that ...
